Walleye Capital
CRL icon

Walleye Capital’s Charles River Laboratories CRL Stock Holding History

Walleye Capital’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$431K Buy
2,500
+2,300
+1,150% +$426K ﹤0.01% 2779
2025
Q4 		$39.9K Sell
200
-5,000
-96% -$907K ﹤0.01% 4134
2025
Q3 		$814K Buy
5,200
+2,900
+126% +$461K ﹤0.01% 2254
2025
Q2 		$349K Buy
2,300
+1,600
+229% +$213K ﹤0.01% 2936
2025
Q1 		$105K Sell
700
-800
-53% -$134K ﹤0.01% 3596
2024
Q4 		$277K Buy
1,500
+1,200
+400% +$231K ﹤0.01% 3487
2024
Q3 		$59.1K Sell
300
-600
-67% -$125K ﹤0.01% 4588
2024
Q2 		$186K Sell
900
-21,500
-96% -$4.87M ﹤0.01% 4357
2024
Q1 		$6.07M Sell
22,400
-14,700
-40% -$3.51M 0.01% 1164
2023
Q4 		$8.77M Sell
37,100
-1,700
-4% -$334K 0.02% 733
2023
Q3 		$7.6M Buy
38,800
+20,400
+111% +$4.19M 0.02% 740
2023
Q2 		$3.87M Buy
18,400
+9,800
+114% +$1.95M 0.01% 892
2023
Q1 		$1.74M Buy
+8,600
New +$1.95M 0.03% 809
2022
Q4 		– Sell
-1,100
Closed -$216K – 3258
2022
Q3 		$216K Buy
+1,100
New +$237K ﹤0.01% 2055
2019
Q4 		– Sell
-1,300
Closed -$172K – 1866
2019
Q3 		$172K Sell
1,300
-600
-32% -$80.4K 0.01% 1255
2019
Q2 		$270K Sell
1,900
-400
-17% -$54.3K 0.03% 789
2019
Q1 		$334K Buy
+2,300
New +$302K 0.06% 552

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Walleye Capital's CRL Position: Q1 2026 in Review

Walleye Capital reduced its Charles River Laboratories (CRL) stake by 99% in Q1 2026, selling an estimated $46.2M and leaving 1,932 shares worth $333K. The position accounts for ﹤0.01% of the portfolio, ranked #2990.

Walleye Capital first reported a position in CRL in Q1 2019 and has held it in 16 quarters since. The position peaked at $50.1M in Q4 2025. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Walleye Capital held 1,932 shares of Charles River Laboratories worth $333K as of Q1 2026.
  • Walleye Capital sold 249,189 Charles River Laboratories shares in Q1 2026, an estimated $46.2M.
  • Charles River Laboratories made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #2990 holding.
  • Walleye Capital first reported a position in Charles River Laboratories in Q1 2019 and has held it in 16 quarters since.
  • Walleye Capital's Charles River Laboratories position peaked at $50.1M in Q4 2025.
  • 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.